331729-57-8

Basic information

• Product Name: Benzoic acid, 5-fluoro-2-(phenylmethoxy)-, phenylmethyl ester
• CAS NO: 331729-57-8
• Molecular Formula: C21H17FO3
• Molecular Weight: 336.363
• Mol File: 331729-57-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 5-fluoro-2-(phenylmethoxy)-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 5-fluoro-2-(phenylmethoxy)-, phenylmethyl ester(331729-57-8)
• EPA Substance Registry System: Benzoic acid, 5-fluoro-2-(phenylmethoxy)-, phenylmethyl ester(331729-57-8)

Safety Data

• Hazardous Substances Data: 331729-57-8(Hazardous Substances Data)

Upstream product

• 345-16-4 5-fluoro-2-hydroxybenzoic acid 
• 100-39-0 benzyl bromide 

Downstream Products

• 847256-14-8 5-fluoro-2-[(phenylmethyl)oxy]benzoic acid 
• 1285513-51-0 5-fluoro-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide 
• 906355-38-2 2-(benzyloxy)-5-fluoro-N-methoxy-N-methylbenzamide 

Relevant articles and documents

Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors

Leucine-rich repeat kinase 2 (LRRK2) has been suggested as a potential therapeutic target for Parkinson's disease. Herein we report the discovery of 5-substituent-N-arylbenzamide derivatives as novel LRRK2 inhibitors. Extensive SAR study led to the discovery of compounds 8e, which demonstrated potent LRRK2 inhibition activity, high selectivity across the kinome, good brain exposure, and high oral bioavailability.

MITOTIC KINESIN INHIBITORS

The present invention relates to tricyclic pyrazoles that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also relates to compositions whic

AZEPANES AND THEIR RING HOMOLOGUES HAVING PROTEIN KINASE INHIBITING ACTIVITY

-